Ardent Health (ARDT) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 20, 2026, via virtual webcast, with voting on director elections, executive compensation, auditor ratification, and other business.

• Record date for voting is March 26, 2026; 43,095,662 shares of common stock outstanding and entitled to vote.

• Forward-looking statements address future financial performance, business strategy, and industry outlook, subject to risks and uncertainties.

Voting matters and shareholder proposals

• Proposals include election of 11 directors, advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor.

• Board recommends voting FOR all director nominees, executive compensation, and auditor ratification.

• Shareholders may submit proposals and director nominations for the 2027 annual meeting following specific bylaw procedures.

Board of directors and corporate governance

• Board consists of 11 members with diverse backgrounds in healthcare, finance, law, and investment.

• EGI-AM and ALH Holdings (Ventas) have nomination rights for board seats based on ownership levels.

• Nine directors are independent under NYSE rules; independence reviewed annually.

• Four standing committees: Audit and Compliance, Nominating and Corporate Governance, Compensation, and Patient Safety and Quality of Care.

• Board leadership structure separates Chairman and CEO roles; annual assessment of leadership structure.